Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Cell Division Protein FtsZ (ftsz) – Pipeline Review, H2 2016

Thursday, September 22, 2016 3:22
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Cell Division Protein FtsZ (ftsz) Therapeutic Market 2016

Complete Report Details @ https://www.wiseguyreports.com/reports/649750-cell-division-protein-ftsz-ftsz-pipeline-review-h2-2016

The, ‘Cell Division Protein FtsZ (ftsz) – Pipeline Review, H2 2016’, provides in depth analysis on Cell Division Protein FtsZ (ftsz) targeted pipeline therapeutics.

The report provides comprehensive information on the Cell Division Protein FtsZ (ftsz), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Cell Division Protein FtsZ (ftsz) targeted therapeutics development and features dormant and discontinued projects.

For more information or any query mail at sales@wiseguyreports.com

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/649750-cell-division-protein-ftsz-ftsz-pipeline-review-h2-2016

Scope

- The report provides a snapshot of the global therapeutic landscape for Cell Division Protein FtsZ (ftsz) 
- The report reviews Cell Division Protein FtsZ (ftsz) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in Cell Division Protein FtsZ (ftsz) targeted therapeutics and enlists all their major and minor projects 
- The report assesses Cell Division Protein FtsZ (ftsz) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report summarizes all the dormant and discontinued pipeline projects 
- The report reviews latest news and deals related to Cell Division Protein FtsZ (ftsz) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand the targeted therapy areas and indications for Cell Division Protein FtsZ (ftsz) 
- Identify the use of drugs for target identification and drug repurposing 
- Identify potential new clients or partners in the target demographic 
- Develop strategic initiatives by understanding the focus areas of leading companies 
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics 
- Devise corrective measures for pipeline projects by understanding Cell Division Protein FtsZ (ftsz) development landscape 
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table Of Contents – Major Key Points

#Companies Involved in Therapeutics Development:

Gero Corp 20 
TAXIS Pharmaceuticals, Inc. 21 
Vichem Chemie Research Ltd. 22 

Cell Division Protein FtsZ (ftsz) – Drug Profiles 23 
BIZ-20131 – Drug Profile 23 
Product Description 23 
Mechanism Of Action 23 
R&D Progress 23 
BIZ-20132 – Drug Profile 24 
Product Description 24 
Mechanism Of Action 24 
R&D Progress 24 
BIZ-20133 – Drug Profile 25 
Product Description 25 
Mechanism Of Action 25 
R&D Progress 25 
chrysophaentin – Drug Profile 26 
Product Description 26 
Mechanism Of Action 26 
R&D Progress 26 
SBP-17GA20 – Drug Profile 27 
Product Description 27 
Mechanism Of Action 27 
R&D Progress 27 

Small Molecules to Inhibit FtsZ for MRSA Infections – Drug Profile 28 
Product Description 28 
Mechanism Of Action 28 
R&D Progress 28 

Small Molecules to Inhibit FtsZ for Tuberculosis – Drug Profile 29 
Product Description 29 
Mechanism Of Action 29 
R&D Progress 29 

Small Molecules to Inhibit FtsZ Protein for MRSA and VRE Infections – Drug Profile 30 
Product Description 30 
Mechanism Of Action 30 
R&D Progress 30 
TXA-497 – Drug Profile 31 
Product Description 31 
Mechanism Of Action 31 
R&D Progress 31 
TXA-709 – Drug Profile 32 
Product Description 32 
Mechanism Of Action 32 
R&D Progress 32 

…….CONTUNUED

For more information or any query mail at sales@wiseguyreports.com

Get Exclusive Discount On This Report @ https://www.wiseguyreports.com/check-discount/649750-cell-division-protein-ftsz-ftsz-pipeline-review-h2-2016

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.